Manuscript
Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL
Erenesto Maddaloni et al.
Diabetes Care 2025;48:235-242
Manuscript
The science of diabetes and a life of trials: The 2024 Banting Medal for Scientific Achievement Lecture
Rury R. Holman
Diabetes 2025;74:164-174
Manuscript
The legacy effect of hyperglycaemia in type 2 diabetes - Authors' reply
Amanda I Adler et al.
Lancet 2025;405:29
Manuscript
Using QALYs as an outcome for assessing global prediction accuracy in diabetes simulation models
Helen A Dakin et al.
Med Decis Making 2025;45:45-59
Manuscript
Great Debate: Pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction
Nikolaus Marx et al.
European Heart Journal 2024;45:5117-5126
Manuscript
Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92)
Beryl Lin et al.
Lancet Diabetes Endocrinol. 2024;12:904-914